Vcare Meds Private Limited - Company Profile

It is a pharma private limited company based in Delhi, India, established in 2013.
2013 Delhi, India Struck Off
Last Updated:
About Vcare Meds Private Limited

Vcare Meds Private Limited, a struck off private limited company, was established on 18 February 2013 in Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U33100DL2013PTC248436. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.

It upholds a compliant status. Its leadership includes Jatin Pahwa (Director), Tarun Dhingra (Director). Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 2655, Basement Hudson Line, Gtb Nagar India, Delhi, Delhi, 110009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U33100DL2013PTC248436

  • Registration Number

    248436

  • Incorporation Date

    18 February 2013

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 13 Year, 10 Days
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth **** 5610.06%
  • Profit Growth **** -3.23%
  • Ebitda **** -187.71%
  • Net Worth -52.31%
  • Total Assets -13.97%
Company report

Vcare Meds Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Vcare Meds Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Vcare Meds Private Limited?
Current Directors
Name Designation Appointment Date Status
Jatin Pahwa Director 18 Feb 2013 Current
Tarun Dhingra Director 18 Feb 2013 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vcare Meds.

Vcare Meds Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 5610.06% increase. The company also saw a slight decrease in profitability, with a 3.23% decrease in profit. The company's net worth observed a substantial decline by a decrease of 52.31%.

Vcare Meds revenue growth over time
Vcare Meds profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
5610.06%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
-13.97%
*******
*******
*******
*******
Profit or Loss
*******
-3.23%
*******
*******
*******
*******
Net Worth
*******
-52.31%
*******
*******
*******
*******
EBITDA
*******
-187.71%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vcare Meds?

Unlock access to Vcare Meds's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Vcare Meds?

Unlock and access historical data on people associated with Vcare Meds, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vcare Meds, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vcare Meds's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vcare Meds
Recent Activity within the Organization
  • Annual General Meeting

    Vcare Meds Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Vcare Meds Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was completed.

  • Director Appointment

    The activity Jatin Pahwa was appointed as a Director was appointed as a Director on 18 Feb 2013 & has been associated with this company since 13 years 10 days . was completed.

  • Director Appointment

    Tarun Dhingra was appointed as a Director was appointed as a Director on 18 Feb 2013 & has been associated with this company since 13 years 10 days . was recorded as a recent event.

  • Company Incorporation

    Progress on Vcare Meds Private Limited was registered on 18 Feb 2013 with Roc Delhi & aged 13 years 10 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Vcare Meds Private Limited?

The CIN of Vcare Meds Private Limited is U33100DL2013PTC248436.

Where is Vcare Meds Private Limited headquartered?

Vcare Meds Private Limited is headquartered at 2655, Basement Hudson Line, Gtb Nagar India, Delhi, Delhi, 110009.

When was Vcare Meds Private Limited incorporated?

Vcare Meds Private Limited was incorporated on 18 February 2013.

Who are the current directors of Vcare Meds Private Limited?

The current directors of Vcare Meds Private Limited are

What is the primary industry of Vcare Meds Private Limited?

The primary industry of Vcare Meds Private Limited is Trade.

Is Vcare Meds Private Limited a listed company?

Vcare Meds Private Limited is unlisted.

What is the capital structure of Vcare Meds Private Limited?

The authorized capital of Vcare Meds Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.

What is the compliance status of Vcare Meds Private Limited?

The compliance status of Vcare Meds Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available